Ramipril

CAS 87333-19-5 17 current records 5 historicalSmall Molecule

Who holds supplier records for Ramipril? 17 organisations hold a current record for Ramipril: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (11), China (2), Germany (1), Hungary (1) and 2 other countries (2).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Ramipril: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ramipril

Reading the evidence

  • 17 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    11 of the 17 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (17)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Ramipril. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Ramipril sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (14)

Certificates of Suitability on the EDQM register for Ramipril, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 23 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZENTIVA K.S. PragueCZ
CEP 2024-053 - Rev 00
Ramipril
Jun 2026Inspected Jun 2026
Czechia
EGIS Pharmaceuticals PLC BudapestHU
CEP 2020-284 - Rev 02
Ramipril, RMP
Dec 2025Inspected Nov 2025
Hungary
NEULAND LABORATORIES LIMITED HyderabadIN
CEP 2003-219 - Rev 08
Ramipril
May 2025—
ZHEJIANG CHANGMING PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2010-176 - Rev 01
Ramipril
Mar 2025—
HETERO LABS LIMITED HyderabadIN
CEP 2021-281 - Rev 01
Ramipril, Process-II
Mar 2025—
AARTI PHARMALABS LIMITED Mulund (W), MumbaiIN
CEP 2009-083 - Rev 06
Ramipril, Grade A
Mar 2025—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2003-050 - Rev 10
Ramipril
Mar 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2004-222 - Rev 05
Ramipril
Nov 2023—
EUROAPI GERMANY GmbH Frankfurt am MainDE
R1-CEP 2001-297 - Rev 07
Ramipril
Dec 2021—
MELODY HEALTHCARE PVT. LTD. BoisarIN
R1-CEP 2008-220 - Rev 03
Ramipril
Nov 2019—
Farmhispania, S.A. MontmelóES
R1-CEP 2004-224 - Rev 02
Ramipril
Oct 2019—
CIPLA LIMITED MumbaiIN
R1-CEP 2007-024 - Rev 03
Ramipril
Oct 2019—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. LinhaiCN
R1-CEP 2003-026 - Rev 03
Ramipril
Oct 2019—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
R1-CEP 2002-196 - Rev 04
Ramipril
Sept 2019—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Ramipril are no longer active. These show a past filing, not current supply.

Show all 5 historical records
  • India · Inactive DMF 21402 · filed Feb 2008
  • RANBAXY LABORATORIES LTD
    Inactive DMF 20380 · filed Mar 2007
  • India · Inactive DMF 19719 · filed Aug 2006
  • SMS Pharmaceuticals limited
    India · Inactive DMF 17401 · filed May 2004
  • ESTEVE QUIMICA SA
    Inactive DMF 16900 · filed Oct 2003

Overview

Ramipril is an angiotensin-converting enzyme (ACE) inhibitor used primarily to treat high blood pressure and congestive heart failure. It works by relaxing blood vessels so that blood can flow more easily.

Chemical identity

IUPAC name
(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid
Canonical SMILES
CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O
InChIKey
HDACQVRGBOVJII-SHCCMQHASA-N
Synonyms
Altace API; HOE-498

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Angiotensin Converting Enzyme Inhibitor
Mechanism of action
Angiotensin-converting Enzyme Inhibitors

Therapeutic areas

CardiovascularHypertensionHeart Failure

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Ramipril?

17 organisations hold an active US FDA Type II Drug Master File or a CEP for Ramipril: AARTI PHARMALABS LIMITED (India), APITORIA PHARMA PRIVATE LTD (India), Cipla Limited (India), Dr. Reddy's Laboratories Ltd. (India), EUROAPI GERMANY GMBH (Germany), Hetero Labs Limited (India), Neuland Laboratories Limited (India) and Zhejiang Huahai Pharmaceutical Co., Ltd. (China), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Ramipril Drug Master Files are active?

AARTI PHARMALABS LIMITED (DMF 19714), APITORIA PHARMA PRIVATE LTD (DMF 17570), Cipla Limited (DMF 17033), Dr. Reddy's Laboratories Ltd. (DMF 16193), EUROAPI GERMANY GMBH (DMF 15208, 37506), Hetero Labs Limited (DMF 18338), Neuland Laboratories Limited (DMF 16647) and Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 24650) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Ramipril records mean?

5 organisations have only inactive Type II DMFs for Ramipril. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Ramipril have a European Certificate of Suitability?

Yes. 14 organisations hold a valid CEP for Ramipril on the EDQM register, including ZENTIVA K.S. Prague (CZ), EGIS Pharmaceuticals PLC Budapest (HU), NEULAND LABORATORIES LIMITED Hyderabad (IN), ZHEJIANG CHANGMING PHARMACEUTICAL CO., LTD. Taizhou (CN), HETERO LABS LIMITED Hyderabad (IN) and AARTI PHARMALABS LIMITED Mulund (W), Mumbai (IN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Ramipril supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Ramipril?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.